Project Grant K23MH136923
- This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $193,754 to The Children's Hospital Corporation (dba Boston Children's Hospital) to develop an implementation strategy for pre-exposure prophylaxis (PrEP) in pediatric primary care settings. The key objectives are to: 1) explore barriers and facilitators to PrEP discussions, prescribing, and persistence among adolescents and young adults...
- This $731,738 Project Grant awarded by the National Institute of Mental Health (CFDA 93.242 Mental Health Research Grants) will fund a pilot feasibility study to integrate pre-exposure prophylaxis (PrEP) into emergency department and urgent care settings using a patient-centered decision support tool. The goal is to improve PrEP awareness, access, and uptake among groups at highest risk for acquiring HIV, such as men who have sex with men, young people, racial/ethnic minorities, and women of...
- This federal Project Grant award titled "STREAMLINING TELEHEALTH FOR EXPANDED PREP UTILIZATION THROUGH COMMUNITY PARTNERSHIPS (STEP-UP)" is funded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242). The $744,279 award, effective from September 18, 2025 to September 17, 2028, supports the development and evaluation of an innovative model that positions community-based organizations (CBOs) as hubs for delivering pre-exposure...
- This Project Grant award, funded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), aims to develop and pilot test a community health worker-delivered PrEP decision aid to facilitate PrEP initiation among Black women seeking HIV testing services in Eastern Virginia. The $179,731 award, with a project period from September 1, 2025 to August 31, 2030, will involve in-depth qualitative interviews to inform the adaptation of a PrEP...
- This federal Project Grant award of $691,620.00 from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), will support the development of an online decision support approach leveraging social media to promote pre-exposure prophylaxis (PrEP) awareness and demand among women in the Southeastern United States. The key products and services to be delivered through this 3-year project include: Developing a replicable social media targeting...
- This $286,660 Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) aims to finalize intervention materials, clinical protocols, and an implementation plan for a nurse-led, same-day HIV pre-exposure prophylaxis (PrEP) initiation intervention with continuation of care services after incarceration. The grant recipient, Rhode Island Hospital, a division of Lifespan Corporation, will test this intervention through a preliminary...
- This $5.37 million project grant from the National Institutes of Health National Institute on Drug Abuse will fund the development of a context-aware digital adherence intervention called SMARTSTEPS to improve pre-exposure prophylaxis (PrEP) adherence among men who have sex with men with substance use disorder. The grant will support two phases. Phase I will inform the specification of an algorithm that utilizes digital phenotyping data from a smartphone app to anticipate non-adherence based...
- This $677,589 Project Grant award from the National Institutes of Health (NIH) Office of the Director's Trans-NIH Research Support program (CFDA 93.310) supports the development and pilot testing of a novel HIV prevention program targeting women experiencing incarceration. The "FIT for PrEP" (F4P) program aims to link these high-risk women to post-release pre-exposure prophylaxis (PrEP) services and address associated social determinants of health during community re-entry. Key aspects...
- This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $680,644 to the University of Alabama at Birmingham (UAB) to evaluate the "Healthy Families-PREP" intervention. This intervention aims to promote the use of pre-exposure prophylaxis (PrEP) among periconception, pregnant, and postpartum women in rural Uganda to reduce HIV incidence. The 5-year project will first adapt the 3-session...
- This federal Project Grant award for $657,907 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will support a 5-year longitudinal analysis to understand the impact of expanding pharmacists' scope of practice on the uptake and retention of pre-exposure prophylaxis (PrEP) for HIV prevention. The project aims to integrate multiple data sources, including policy, census, survey, and medical claims data, to...
TELEPHONE INITIATED PREP POST-ED DISCHARGE (TIPPED) - PROJECT SUMMARY THE OVERARCHING AIM OF THIS RESEARCH AND CAREER DEVELOPMENT PLAN IS FOR DR. SOLNICK, THE PRINCIPAL INVESTIGATOR (PI), TO ESTABLISH HERSELF AS AN INDEPENDENT PHYSICIAN-INVESTIGATOR WHOSE RESEARCH FOCUSES ON ADVANCING HIV PREVENTION CARE FOR INDIVIDUALS DIAGNOSED WITH SEXUALLY TRANSMITTED INFECTIONS (STIS) IN EMERGENCY DEPARTMENTS (EDS). EDS HAVE GREAT POTENTIAL AS UNDERUTILIZED ALLIES IN THE EFFORT TO END THE HIV/AIDS EPIDEMIC. EDS ESPECIALLY COULD BE USEFUL IN INCREASING THE INITIATION OF HIV PRE-EXPOSURE PROPHYLAXIS (PREP) - A KEY COMPONENT OF THE NATIONAL HIV/AIDS STRATEGY. EDS COULD BE USED AS AN ACCESS POINT WHERE HIGHER HIV-RISK INDIVIDUALS, PARTICULARLY THOSE WITH STIS, CAN BE INITIATED ON PREP AND REFERRED FOR FURTHER OUTPATIENT MAINTENANCE ON PREP. DR. SOLNICK'S K23 RESEARCH PROJECT AIMS TO IMPROVE ED-BASED HIV PREVENTION IN STI-DIAGNOSED PATIENTS BY DEVELOPING AND EVALUATING A PROTOCOL FOR TELEPHONE INITIATED PREP POST-ED DISCHARGE (TIPPED). THE SPECIFIC AIMS OF HER K23 RESEARCH PROJECT ARE TO (1) DEVELOP A STAKEHOLDER-ENGAGED TIPPED PROTOCOL AND IMPLEMENTATION STRATEGY; (2) ADAPT A TAILORED COUNSELING MESSAGE, A PERSUASIVE HEALTH COMMUNICATION INTERVENTION (PHCI), TO ENCOURAGE PREP UPTAKE DURING POST-ED "CALLBACK" SESSIONS AS CONDUCTED BY THE ED CLINICIAN AS PART OF THEIR REGULAR CALLBACK PROCEDURE TO INFORM PATIENTS OF THE STI DIAGNOSES; AND (3) IMPLEMENT AND EVALUATE TIPPED, INCLUDING A NESTED PILOT RANDOMIZED CONTROLLED TRIAL OF PHCI'S IMPACT ON PREP INITIATION AND ADHERENCE. THIS RESEARCH WILL INCORPORATE BOTH EVALUATIONS OF IMPLEMENTATION SCIENCE-FOCUSED PROCESSES OUTCOMES-FEASIBILITY, FIDELITY, ACCEPTABILITY-AND CLINICAL OUTCOMES OF PREP INITIATION, LINKAGE TO CARE, AND MEDICATION ADHERENCE. ADVANCED STATISTICAL METHODS, SUCH AS INTERRUPTED TIME-SERIES METHODS, WILL BE USED TO ASSESS CLINICAL OUTCOMES. THIS CAREER DEVELOPMENT PLAN WILL ENABLE DR. SOLNICK TO BUILD UPON HER EXPERIENCE AS AN EMERGENCY MEDICINE PHYSICIAN AND HEALTHCARE RESEARCHER TO GAIN NEW EXPERTISE IN (1) IMPLEMENTATION SCIENCE APPROACHES TOWARDS PROTOCOL DEVELOPMENT, DEPLOYMENT, AND ANALYSIS; (2) BEHAVIORAL INTERVENTIONS IN RANDOMIZED CONTROLLED TRIAL DESIGN; AND (3) ADVANCED STATISTICAL METHODS IN TIME-SERIES DATA FROM ELECTRONIC HEALTH RECORDS. SHE WILL RECEIVE IN-DEPTH MENTORSHIP FROM A MULTI-DISCIPLINARY RESEARCH TEAM OF EXPERTS IN THE DOMAINS OF IMPLEMENTATION SCIENCE, THE HIV CARE CONTINUUM, CLINICAL TRIAL DESIGN, BEHAVIORAL INTERVENTIONS, AND STATISTICAL ANALYSIS. THE RESULTS OF THIS K23 WILL GUIDE IMPROVEMENTS TO TIPPED AND FORM THE BASIS FOR DR. SOLNICK'S SUBSEQUENT R01 STUDY. HER FUTURE R01 STUDY WILL EVALUATE PROCESS AND CLINICAL OUTCOMES RELEVANT TO IMPLEMENTING TIPPED IN MULTIPLE EDS. THE PUBLIC HEALTH IMPORTANCE OF THIS WORK IS THAT IT WILL CONTRIBUTE TO EXPANDED HIV PREVENTION DELIVERY AND IMPROVED OUTCOMES FOR INDIVIDUALS AT RISK OF HIV INFECTION, NAMELY THOSE WITH AN STI RECEIVING CARE IN THE ED.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $194.9k | 6/2/25 | ||
| Not listed | $194.9k | 5/10/24 | ||
| Not listed | $194.9k | 5/10/24 |